RxDoctor Payments Data

Surilo Acosta Cadena, MD

Family Medicine · Bayamon, PRNPI 1437152964

Payments from drug & device makers

$998in general payments, 2019–2025

Across 39 payments — averaging $25.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$252
  • Johnson & Johnson$141
  • Boehringer Ingelheim$127
  • Lilly USA, LLC$119
  • Eli Lilly Export S.A. Puerto Rico Branch$105
  • Merck$94
  • plus $160 from 5 others

What the payments were for

  • Food & beverage$998100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$998 in reported general payments places this provider in the 75th percentile of 497 family medicine providers in Puerto Rico.

See all family medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$3,226
Medicare patients
15
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin78$109,768
MounjaroTirzepatide56$67,365
JanumetSitagliptin Phos/Metformin Hcl26$35,306
SynthroidLevothyroxine Sodium234$30,877
TrulicityDulaglutide19$28,503
EliquisApixaban25$22,914
FarxigaDapagliflozin Propanediol19$22,170
TradjentaLinagliptin17$16,831
XareltoRivaroxaban12$15,761
Trijardy XrEmpaglifloz/Linaglip/Metformin12$14,533
Humalog Kwikpen U-200Insulin Lispro16$10,515
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,387
Synjardy XrEmpagliflozin/Metformin Hcl14$9,048
Omega-3 Acid Ethyl Esters71$8,371
Breo ElliptaFluticasone/Vilanterol19$7,897

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Trijardy Xr, Synjardy Xr$127$150,180121 claims
Lilly USA, LLCMounjaro, Trulicity$119$95,86875 claims
MerckJanumet$94$35,30626 claims
AbbVieSynthroid$25$30,877234 claims
AstraZenecaFarxiga, Symbicort$252$24,95631 claims
Johnson & JohnsonXarelto$141$15,76112 claims
Sanofi-aventis U.S. LLCLantus$20$1,98824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 497 family medicine providers in Puerto Rico.

Other family medicine in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →